Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
bioMérieux S.A. stock logo
BMXMF
bioMérieux
$129.67
0.0%
$128.20
$93.50
$136.40
$15.35B0.741,233 shs4 shs
Eurofins Scientific SE stock logo
ERFSF
Eurofins Scientific
$62.67
-3.0%
$59.17
$44.61
$67.74
$12.09B0.681,702 shs1,326 shs
Shionogi & Co., Ltd. stock logo
SGIOY
Shionogi & Co., Ltd.
$8.17
-1.6%
$7.96
$6.22
$8.72
$13.90B0.19119,547 shs74,820 shs
Sysmex Co. stock logo
SSMXY
Sysmex
$16.82
-1.8%
$18.20
$14.38
$22.00
$10.59B1.2271,340 shs57,263 shs
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
bioMérieux S.A. stock logo
BMXMF
bioMérieux
0.00%0.00%-0.78%+7.69%+27.29%
Eurofins Scientific SE stock logo
ERFSF
Eurofins Scientific
-0.51%+0.14%+5.05%+28.05%+3.29%
Shionogi & Co., Ltd. stock logo
SGIOY
Shionogi & Co., Ltd.
+2.34%+5.80%-0.84%+7.24%-24.34%
Sysmex Co. stock logo
SSMXY
Sysmex
+1.42%+2.00%-7.85%-6.85%+0.65%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
bioMérieux S.A. stock logo
BMXMF
bioMérieux
N/AN/AN/AN/AN/AN/AN/AN/A
Eurofins Scientific SE stock logo
ERFSF
Eurofins Scientific
N/AN/AN/AN/AN/AN/AN/AN/A
Shionogi & Co., Ltd. stock logo
SGIOY
Shionogi & Co., Ltd.
0.9756 of 5 stars
0.05.01.70.00.00.01.3
Sysmex Co. stock logo
SSMXY
Sysmex
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
bioMérieux S.A. stock logo
BMXMF
bioMérieux
3.00
BuyN/AN/A
Eurofins Scientific SE stock logo
ERFSF
Eurofins Scientific
2.33
HoldN/AN/A
Shionogi & Co., Ltd. stock logo
SGIOY
Shionogi & Co., Ltd.
0.00
N/AN/AN/A
Sysmex Co. stock logo
SSMXY
Sysmex
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest SSMXY, SGIOY, ERFSF, and BMXMF Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/7/2025
bioMérieux S.A. stock logo
BMXMF
bioMérieux
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeModerate Buy ➝ Hold
4/25/2025
Eurofins Scientific SE stock logo
ERFSF
Eurofins Scientific
HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeHold
4/25/2025
Eurofins Scientific SE stock logo
ERFSF
Eurofins Scientific
Hsbc Global Res
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
(Data available from 5/28/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
bioMérieux S.A. stock logo
BMXMF
bioMérieux
$3.98B3.86$5.74 per share22.58$34.31 per share3.78
Eurofins Scientific SE stock logo
ERFSF
Eurofins Scientific
$7.52B1.61$8.06 per share7.78N/A
Shionogi & Co., Ltd. stock logo
SGIOY
Shionogi & Co., Ltd.
$3.01B4.61$0.79 per share10.34$5.29 per share1.54
Sysmex Co. stock logo
SSMXY
Sysmex
$3.20B3.31$0.85 per share19.81$4.56 per share3.69
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
bioMérieux S.A. stock logo
BMXMF
bioMérieux
$387.03MN/A0.00N/AN/AN/AN/AN/A
Eurofins Scientific SE stock logo
ERFSF
Eurofins Scientific
$439.38MN/A0.0015.95N/AN/AN/AN/A7/24/2025 (Estimated)
Shionogi & Co., Ltd. stock logo
SGIOY
Shionogi & Co., Ltd.
$1.12BN/A13.5912.572.3735.53%12.02%10.64%8/4/2025 (Estimated)
Sysmex Co. stock logo
SSMXY
Sysmex
$328.73M$0.5630.0421.56N/AN/AN/AN/A8/5/2025 (Estimated)

Latest SSMXY, SGIOY, ERFSF, and BMXMF Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/14/2025Q4 2025
Sysmex Co. stock logo
SSMXY
Sysmex
$0.1617$0.12-$0.0417$0.12$991.22 million$958.89 million
5/12/2025Q4 2025
Shionogi & Co., Ltd. stock logo
SGIOY
Shionogi & Co., Ltd.
$0.1654$0.14-$0.0254$0.14$824.23 million$721.77 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
bioMérieux S.A. stock logo
BMXMF
bioMérieux
N/AN/AN/AN/AN/A
Eurofins Scientific SE stock logo
ERFSF
Eurofins Scientific
N/AN/AN/AN/AN/A
Shionogi & Co., Ltd. stock logo
SGIOY
Shionogi & Co., Ltd.
$0.111.35%N/AN/AN/A
Sysmex Co. stock logo
SSMXY
Sysmex
$0.120.71%N/A21.43%N/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
bioMérieux S.A. stock logo
BMXMF
bioMérieux
0.10
2.21
1.20
Eurofins Scientific SE stock logo
ERFSF
Eurofins Scientific
0.64
1.42
1.34
Shionogi & Co., Ltd. stock logo
SGIOY
Shionogi & Co., Ltd.
0.01
7.64
7.01
Sysmex Co. stock logo
SSMXY
Sysmex
0.11
3.19
2.42

Institutional Ownership

CompanyInstitutional Ownership
bioMérieux S.A. stock logo
BMXMF
bioMérieux
N/A
Eurofins Scientific SE stock logo
ERFSF
Eurofins Scientific
N/A
Shionogi & Co., Ltd. stock logo
SGIOY
Shionogi & Co., Ltd.
1.92%
Sysmex Co. stock logo
SSMXY
Sysmex
N/A

Insider Ownership

CompanyInsider Ownership
bioMérieux S.A. stock logo
BMXMF
bioMérieux
N/A
Eurofins Scientific SE stock logo
ERFSF
Eurofins Scientific
N/A
Shionogi & Co., Ltd. stock logo
SGIOY
Shionogi & Co., Ltd.
N/A
Sysmex Co. stock logo
SSMXY
Sysmex
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
bioMérieux S.A. stock logo
BMXMF
bioMérieux
14,600118.36 millionN/ANot Optionable
Eurofins Scientific SE stock logo
ERFSF
Eurofins Scientific
61,798192.98 millionN/ANot Optionable
Shionogi & Co., Ltd. stock logo
SGIOY
Shionogi & Co., Ltd.
5,6901.70 billionN/ANot Optionable
Sysmex Co. stock logo
SSMXY
Sysmex
11,012629.47 millionN/ANot Optionable

Recent News About These Companies

Harding Loevner International Equity ADR Q3 2024 Report
NCLTY Nitori Holdings Co., Ltd.
Jefferies Sticks to Its Buy Rating for Sysmex (SSMXF)
Sysmex Corporation (SSMXY)

Media Sentiment Over Time

bioMérieux stock logo

bioMérieux OTCMKTS:BMXMF

$129.67 -0.06 (-0.05%)
As of 09:30 AM Eastern

bioMérieux S.A. develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems that use biological samples, such as blood, saliva, urine, etc. for the diagnosis of infectious diseases, including bacterial infections, parasitic infections, and viral infections; and microbiological control of production or the production environment primarily for food, pharmaceutical, and cosmetic industries. It also provides a suite of software products and services that collect, analyze, and merge various sources of data to make decisions under the BIOMÉRIEUX VISION SUITE name; designs, manufactures, and maintains instruments and software; and designs and manufactures reagents for in vitro diagnostic tests. The company serves clinical and hospital laboratories, physicians, blood banks, vets, and industrial control laboratories. bioMérieux S.A. was formerly known as B-D Mérieux. The company was founded in 1963 and is headquartered in Marcy-l'Étoile, France. bioMérieux S.A. is a subsidiary of Institut Mérieux SA.

Eurofins Scientific stock logo

Eurofins Scientific OTCMKTS:ERFSF

$62.67 -1.92 (-2.97%)
As of 03:08 PM Eastern

Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of various analytical methods and tests to evaluate the safety, identity, composition, authenticity, origin, traceability, and purity of various products. It provides services such as agroscience, including biological assessment, consumer and human, and environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, such as product inspection, auditing, certification, training and consultation of food, consumer products, healthcare and cosmetics, and food supplements; biopharma, and clinical diagnostics. In addition, the company offers consumer product testing, which include sustainability, expert services and regulatory, consumer research and sensory evaluation, audits, testing, certifications and approvals, inspections, and training courses for various industries; cosmetics and personal care; environment testing, including water, air, soil, waste, and other products testing; and food and feed testing that include allergen, GMO, grain, meat, nano material, pesticides, and residual DNA testing. Further, it offers audit and certification, training and consulting; food irradiation and labelling, heavy metals, carbohydrates, radioactivity, nutritional analysis, microbiolody, and testing for persistent organic pollutants, veterinary drug residue, dioxins and organic contaminants, pesticides, mycotoxins, and vitamins, as well as analyses for genetic modifications. Additionally, the company provides forensic, genomic, maritime, materials and engineering, REACH, and other services. The company was founded in 1987 and is headquartered in Luxembourg City, Luxembourg.

Shionogi & Co., Ltd. stock logo

Shionogi & Co., Ltd. OTCMKTS:SGIOY

$8.17 -0.13 (-1.57%)
As of 03:59 PM Eastern

Shionogi & Co., Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan. It offers Fetroja, a multidrug-resistant for gram-negative bacterial infection treatment; Cabenuva and Apretude an anti-HIV and HIV prophylactic drug; Xocova an oral COVID-19 treatment drug; Finibax a carbapenem antibiotic; Xofluza, an influenza antiviral drug; and Tivicay, an anti-HIV drug. It also develops S-872600 an influenza nasal vaccine; S-875670 anCOVID-19 nasal vaccine; S-540956 a nucleic acid adjuvant; S-554110 a nontuberculous mycobacterial infection; S-337395 for RSV infections; S-892216 for COVID-19 therapeutics; Olorofim for invasive aspergillosis; cefiderocol for aerobic gram-negative bacterial infections and infectious diseases; S-268019 a COVID-19 prophylactic vaccine; S-268019 a prophylactic vaccine for COVID-19; ensitrelvir for COVID-19 treatment and prevention; baloxavir for influenza virus infection; S-365598 for HIV infection; and S-555739 for suppressing aggravation of COVID-19. In addition, the company develops S-540956 for nucleic acid adjuvant; S-109802 for post-stroke spasticity; S-151128 for chronic pain; S-588210 and S-531011 for solid tumor; S-309309 for obesity; BPN14770 for Alzheimer's disease and fragile X syndrome; S-588410 for bladder cancer; S-488210 for head and neck squamous cell carcinoma; S-005151 for Acute ischemic stroke and epidermolysis bullosa; Rizmoic for opioid-induced constipation; ADR-001 for decompensated liver cirrhosis; S-222611 for malignant tumor; S-812217 for depression; GRT7039 for pain associated with osteoarthritis of the knee; SDT-001 for inattentive ADHD; S-588410 for esophageal cancer; SR-0379 for cutaneous ulcer; and S-723595 for type 2 diabetes. The company was formerly known as Shionogi Shoten Co., Ltd. and changed its name to Shionogi & Co., Ltd. in 1943. Shionogi & Co., Ltd. was founded in 1878 and is headquartered in Osaka, Japan.

Sysmex stock logo

Sysmex OTCMKTS:SSMXY

$16.82 -0.31 (-1.81%)
As of 03:59 PM Eastern

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS. In addition, it offers cancer lymph node metastasis testing systems to detect information to help in diagnosing lymph node metastasis; and lab assay services. Further, the company is involved in the development and sale of software for diagnostic information systems; provision of facility management, office, welfare, and genetic analysis services; development, operation, and maintenance of IT solutions, platforms, and applications related to digital medicine; marketing, development, design, manufacture, sale, and after-sales service related to medical robots; and distribution and after sales support of medical devices and reagents for biotechnology, medical technology, and molecular cell analysis. Additionally, it researches, develops, manufactures, and sells regenerative medicine products; develops, manufactures, and sells biodevices; develops, maintains, and sells computer software; and offers blood DNA testing service. The company serves national and other public hospitals, private hospitals, universities, research institutes, other medical institutions, etc. It also exports its products to approximately 190 countries. The company was formerly known as TOA Medical Electronics Co., Ltd. and changed its name to Sysmex Corporation in October 1998. Sysmex Corporation was founded in 1968 and is headquartered in Kobe, Japan.